357580 — Amosense Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩109bn
- KR₩147bn
- KR₩87bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 62,028 | 43,612 | 56,759 | 63,014 | 87,454 |
Cost of Revenue | |||||
Gross Profit | 16,757 | 4,185 | 10,185 | 16,576 | 18,191 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 61,169 | 55,949 | 61,563 | 62,555 | 87,140 |
Operating Profit | 859 | -12,337 | -4,803 | 459 | 314 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -705 | -15,865 | -7,468 | -2,131 | -319 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,196 | -16,757 | -7,415 | -905 | -1,423 |
Net Income Before Extraordinary Items | |||||
Net Income | -1,196 | -16,757 | -7,415 | -905 | -1,423 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1,196 | -16,757 | -7,415 | -905 | -1,423 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -53.8 | -1,378 | -619 | -57.9 | -101 |
Dividends per Share |